Longeveron Inc. (LGVN)
NASDAQ: LGVN · Real-Time Price · USD
1.109
-0.051 (-4.44%)
Apr 13, 2026, 2:47 PM EDT - Market open
Longeveron Market Cap
Longeveron has a market cap or net worth of $32.46 million as of April 13, 2026. Its market cap has increased by 26.16% in one year.
Market Cap
32.46M
Enterprise Value
30.13M
1-Year Change
26.16%
Ranking
Category
Stock Price
$1.11
Market Cap Chart
Since the IPO on February 12, 2021, Longeveron's market cap has decreased from $172.48M to $32.46M, a decrease of -81.18%. That is a compound annual growth rate of -27.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 33.97M | 214.66% |
| Dec 31, 2025 | 10.79M | -57.95% |
| Dec 31, 2024 | 25.67M | -24.83% |
| Dec 29, 2023 | 34.15M | -49.55% |
| Dec 30, 2022 | 67.68M | -72.36% |
| Dec 31, 2021 | 244.90M | 41.99% |
| Feb 12, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CervoMed | 35.46M |
| Lixte Biotechnology Holdings | 35.43M |
| ABVC BioPharma | 35.33M |
| Palatin Technologies | 34.01M |
| Evaxion | 33.69M |
| Actinium Pharmaceuticals | 33.67M |
| Pluri | 33.37M |
| CEL-SCI | 32.94M |